←
Adrian Sacher, M.D.484 posts
Adrian Sacher, M.D. avatar

Adrian Sacher, M.D.

@DocSacher

Lung oncologist, tumor immunology & KRAS researcher, advocate for lung cancer patients and learners @pmcancercentre, @uoftmedicine, @UofT. He/Him/Il. 🏳️‍🌈

◷ Joined October 2015▧ 3 Photos and videos
Adrian Sacher, M.D. avatar
Adrian Sacher, M.D.@DocSacher·24 Aug 2023

Setting the bar higher for KRAS inhibitors - pleased to share our study of divarasib in KRAS G12C lung/colon/solid tumors in @NEJM. Impressive response rate, durability and tolerability. Thanks to pts and co-investigators. @KRASKickers #lcsm

NEJM@NEJM23 Aug 2023

Among patients with cancers bearing the KRAS G12C mutation who received divarasib at a 400-mg dose, 56% with lung cancer, 36% with colorectal cancer, and 36% with other tumor types had a confirmed response. 🔗 Read the full study results: nej.md/45xZYok #oncology

Natalie Vokes avatar
⟳ Adrian Sacher, M.D. retweeted
Natalie Vokes@NIVokes·11 Mar 2025

It was a pleasure to spend the day @ASCO planning the metastatic NSCLC program with this amazing group (missing Toby Campbell). Looking forward to an exciting #ASCO25 !

Post attachment
OncLive.com avatar
⟳ Adrian Sacher, M.D. retweeted
OncLive.com@OncLive·16 Sep 2024

AMG 193 Shows Preliminary Clinical Activity in MTAP-Deleted Solid Tumors @DocSacher @pmcancercentre @uoftmedicine @UofT #ESMO24 #ESMO2024 #MedTwitter onclive.com/view/amg-193-sho…

Patrick Forde avatar
⟳ Adrian Sacher, M.D. retweeted
Patrick Forde@FordePatrick·24 Apr 2024

Not one, not 2, but 3 lung cancer plenaries at #ASCO24 ! Early telemed pall care, the LAURA trial of consolidation osimertinib after CRT for stage 3 EGFR non small cell lung cancer & the ADRIATIC trial of consolidation immunotherapy after CRT for small cell lung cancer! #lcsm

ASCO@ASCO24 Apr 2024

#ASCO24 garnered a record number of abstract submissions! Preview the abstract titles to see what will be presented or published at this year’s meeting and browse the meeting program to start planning your schedule ➡️ brnw.ch/21wJ8kD

Post attachment
Brad Wouters 🇨🇦 avatar
⟳ Adrian Sacher, M.D. retweeted
Brad Wouters 🇨🇦@bradwouters·5 Oct 2023

Pleased to participate in #Coalition4CdnResearch press conference with all Canadian advocacy groups coming together to call on the federal government to invest in research. @cafreeland @KirstyDuncanMP @JustinTrudeau

"It's past time for the government to make a major investment in Canadian research." - Dr. Brad Wouters, Executive VP Science & Research at @UHN, representing @HealthCareCAN, and a Research Canada Board Director Read #Coalition4CdnResearch's open letter: ow.ly/yXg450PTuPI

Post attachment
Brad Wouters 🇨🇦 avatar
⟳ Adrian Sacher, M.D. retweeted
Brad Wouters 🇨🇦@bradwouters·29 Aug 2023

Exciting new clinical findings from @DocSacher @pmcancercentre @UHN_Research demonstrating potential of targeting KRAS

Dr. Adrian Sacher (@DocSacher) @UHN co-led a multi-national effort to test a new anticancer drug in patients with non-small-cell lung cancer and colon cancer. With few serious side effects found, further testing is warranted. > uhnresearch.ca/news/advancin…; doi.org/10.1056/NEJMoa230381…

Post attachment